Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

But the Globe analysis found that patients taking drugs such as Wegovy, Ozempic, Mounjaro, and Zepbound are disproportionately ... their new insurance plan at CVS Caremark wouldn’t cover Wegovy.

Despite lower-than-expected first-quarter revenues and a guidance cut for 2025, NVO stock price rose post its earnings release. This is because Novo Nordisk said on the first-quarter call that it ...